🇺🇸 PFE — Pfizer Inc.

Salud Compra
← Volver

Precio actual

29,39 USD

Máx. histórico

61,25

1786 días

Split 1054:1000 del 17/11/2020

Caída desde máximo

-52,02%

Rango 52 semanas

23,62 – 31,44

Variación hoy

-0,20%

Cierre anterior

29,88

Rango de hoy

28,54 – 29,43

Volumen hoy

48.232.765

Peor caída histórica

-69,25%

12/04/1999 → 02/03/2009

Recuperado en 1717 días

Volatilidad anualizada ⓘ

27,33%

Información
Nombre completo
Pfizer Inc.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
75.000
PER ⓘ
41,99 (puede no estar actualizado)
Dividend yield
5,76% (puede no estar actualizado)
Precio objetivo analistas
29,72 USD (puede no estar actualizado)
Primera cotización
01/06/1972
Precio actualizado
hace 1 día
Sobre la empresa

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeutic areas comprising amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, and Hympavzi brands; and anti-infective and immunoglobulin medicines under the Zavicefta, Octagam, and Panzyga brands. In addition, the company offers oncology products comprising ADCs, small molecules, bispecific, and other immunotherapies for the treatment of cancers, including breast cancer, genitourinary cancer, and hematologic malignancies, as well as melanoma, gastrointestinal, gynecological, and lung cancer under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. Further, it provides biosimilars under the Inflectra brand; oncology biosimilars comprising Retacrit, Ruxience, Zirabev, Trazimera and Nivestym, and other biosimilars; and sterile injectables, such as Sulperazon, Atgam, Fragmin, Solu Medrol, Solu Cortef, and Bicillin. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as a strategic collaboration with Boltz, PBC to develop and deploy biomolecular AI foundation models. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Dividendos repartidos Total últimos 12 meses: 1,2900 USD · Yield: 4,39%
Fecha de pago Importe por participación
06/05/2015 0,2657 USD
04/02/2015 0,2657 USD
05/11/2014 0,2467 USD
30/07/2014 0,2467 USD
07/05/2014 0,2467 USD
05/02/2014 0,2467 USD
06/11/2013 0,2277 USD
31/07/2013 0,2277 USD
08/05/2013 0,2277 USD
30/01/2013 0,2277 USD
07/11/2012 0,2087 USD
01/08/2012 0,2087 USD
09/05/2012 0,2087 USD
01/02/2012 0,2087 USD
08/11/2011 0,1898 USD
Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2020 1054:1000
01/07/1999 3:1
01/07/1997 2:1
03/07/1995 2:1
01/04/1991 2:1
01/07/1983 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
12/11/1997 21,51 21,98 21,07 21,23 -3,94% 4,23% 11.191.583
11/11/1997 22,06 22,18 21,76 22,10 +1,18% 1,88% 7.085.726
10/11/1997 22,61 22,69 21,82 21,84 -2,39% 3,85% 8.217.406
07/11/1997 22,14 22,49 21,94 22,38 -2,08% 2,50% 13.562.767
06/11/1997 23,32 23,32 22,61 22,85 -2,20% 3,05% 7.902.154
05/11/1997 23,09 23,46 22,83 23,36 +2,78% 2,74% 10.275.868
04/11/1997 22,65 22,97 22,55 22,73 -1,63% 1,83% 7.180.902
03/11/1997 22,63 23,17 22,49 23,11 +2,91% 2,97% 9.355.409
31/10/1997 22,93 22,99 22,20 22,45 -1,05% 3,45% 13.567.510
30/10/1997 22,28 23,68 22,22 22,69 +0,26% 6,57% 16.624.531
29/10/1997 22,93 23,32 22,49 22,63 +0,26% 3,62% 13.970.981
28/10/1997 20,71 22,85 20,56 22,57 +5,35% 11,07% 21.419.388
27/10/1997 22,10 22,55 20,95 21,43 -5,49% 7,25% 12.859.854
24/10/1997 23,09 23,28 22,30 22,67 +0,26% 4,28% 12.408.320
23/10/1997 22,14 22,83 22,14 22,61 -1,12% 3,12% 13.445.773
22/10/1997 22,77 23,09 22,65 22,87 +1,85% 1,91% 14.374.452
21/10/1997 21,51 22,45 21,47 22,45 +6,27% 4,60% 7.292.837
20/10/1997 20,83 21,25 20,48 21,13 +2,49% 3,70% 8.369.498
17/10/1997 20,81 20,99 20,32 20,62 -2,25% 3,23% 12.640.727
16/10/1997 21,64 21,70 20,97 21,09 -1,75% 3,38% 10.178.478
15/10/1997 21,43 21,88 21,23 21,47 +0,00% 3,04% 14.239.751
14/10/1997 20,99 21,51 20,93 21,47 +4,62% 2,73% 15.247.164
13/10/1997 20,56 20,66 20,34 20,52 +0,78% 1,54% 4.710.748
10/10/1997 19,96 20,50 19,96 20,36 +0,59% 2,67% 5.363.384
09/10/1997 20,00 20,64 19,92 20,24 -0,68% 3,56% 7.535.678
08/10/1997 20,52 20,54 19,94 20,38 -0,87% 2,89% 8.742.298
07/10/1997 20,04 20,56 19,90 20,56 +3,59% 3,25% 8.735.657
06/10/1997 19,88 20,08 19,75 19,85 +1,62% 1,69% 5.908.829
03/10/1997 20,12 20,20 19,43 19,53 +0,00% 3,83% 11.537.506
02/10/1997 18,82 19,55 18,80 19,53 +2,49% 3,99% 6.052.068